Physician profile

Sidney K Stein

Pulmonary Disease · New York, NY

NPI 1649326901

$2,201.21

in general payments reported to CMS, 2019-2025

27 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$115.38

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $510.75 2019
Glaxosmithkline, LLC. $468.02 2019-2023
Insmed, INC. $156.05 2019
Grifols USA, LLC $138.34 2019
Amarin Pharma, INC. $114.91 2019
Amgen INC. $103.21 2019
Pfizer INC. $96.82 2019
Takeda Pharmaceuticals U.S.A., INC. $88.21 2019
Allergan, INC. $69.70 2019
Boston Scientific Corporation $50.90 2019-2020
Janssen Pharmaceuticals, INC $45.54 2019
Sanofi Pasteur INC. $37.48 2019
Lilly USA, LLC $35.07 2019
Advanced Respiratory, INC $30.62 2019
Electromed, INC. $29.48 2019
Show all 27 companies

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sidney K Stein

$2,201.21

in general payments reported 2019-2025

Years
2019-2023
Top company
Astrazeneca Pharmaceuticals Lp

https://glasscript.com/doctor/210802/sidney-k-stein

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.